Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: A VigiBase Study

Am J Respir Crit Care Med. 2023 May 1;207(9):1253-1255. doi: 10.1164/rccm.202210-1898LE.

Philippine Lifar¹, François Montastruc^{2

3}, Laurent L Reber⁴, Jean-François Magnaval⁵, Laurent Guilleminault^{1

4}

¹ Department of Respiratory Medicine.
² Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology.
³ Centre of Clinical Investigation 1436, Team PEPSS "Pharmacology in Population cohortS and biobankS", Toulouse University Hospital Centre, Toulouse, France; and.
⁴ Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm U1291, University of Toulouse, CNRS U5282, F-CRIN CRISALIS, Toulouse, France.
⁵ Department of Clinical Parasitology, Faculty of Medicine, and.

No abstract available

Publication types